"FDA Clears Weight-Loss Drugs of Suicidal Thoughts Risk"
TL;DR
The FDA conducted a preliminary review and found no clear link between popular weight-loss drugs, such as Mounjaro, Ozempic, Wegovy, and Zepbound, and suicidal thoughts. While the agency cautioned that a small risk cannot be definitively ruled out, it emphasized that the benefits of these medications outweigh their risks when used according to FDA-approved labeling. The drugs, which mimic natural hormones and are part of the GLP-1 class, have been under scrutiny for potential side effects, including thoughts of suicide. A recent study also found no higher risk of suicidal thoughts among patients taking semaglutide for weight loss or diabetes.
Topics:businesshealth-medicine#fda#glp-1#health-medicine#mental-health#suicidal-thoughts#weight-loss-drugs
- FDA reports no link between weight-loss drugs and suicidal thoughts The Washington Post
- Weight-Loss Drugs Don't Cause Suicidal Thoughts, FDA Says The Wall Street Journal
- FDA finds no evidence that Ozempic, similar drugs cause suicidal thoughts in preliminary evaluation CNN
- Pharmalittle: We're reading about GLP-1 drugs' safety, Novartis nixing a deal, and more STAT
- AP Trending SummaryBrief at 2:46 p.m. EST | National | heraldpalladium.com Herald Palladium
Want the full story? Read the original reporting
Read on The Washington Post